[HTML][HTML] Brain gliomas: diagnostic and therapeutic issues and the prospects of drug-targeted nano-delivery technology
B Song, X Wang, L Qin, S Hussain, W Liang - Pharmacological Research, 2024 - Elsevier
Glioma is the most common intracranial malignant tumor, with severe difficulty in treatment
and a low patient survival rate. Due to the heterogeneity and invasiveness of tumors, lack of …
and a low patient survival rate. Due to the heterogeneity and invasiveness of tumors, lack of …
Recent Developments in Glioblastoma‐On‐A‐Chip for Advanced Drug Screening Applications
Glioblastoma (GBM) is an aggressive form of cancer, comprising≈ 80% of malignant brain
tumors. However, there are no effective treatments for GBM due to its heterogeneity and the …
tumors. However, there are no effective treatments for GBM due to its heterogeneity and the …
[HTML][HTML] 158| Intraoperative Brain Mapping–A Conversation With Dr. Vigneswaran Veeramuthu and Dr. Dave Sabsevitz
M Story - navneuro.com
In this episode we highlight topics such as the meaning and evolution of the term “eloquent
cortex,” localized versus distributed models of brain functioning, aggressiveness versus …
cortex,” localized versus distributed models of brain functioning, aggressiveness versus …